Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis

被引：12

作者：

Kozak, Margaret M. ^{[1
]}

Xiang, Michael ^{[1
]}

Pollom, Erqi L. ^{[1
]}

Horst, Kathleen C. ^{[1
]}

机构：

[1] Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA 94305 USA

来源：

BREAST JOURNAL | 2019年 / 25卷 / 03期

关键词：

breast cancer; chemotherapy; outcomes; radiation treatment; triple negative; CHEMOTHERAPY; OUTCOMES; AGE;

D O I：

10.1111/tbj.13251

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with triple negative breast cancer were identified using the Surveillance, Epidemiology, and End Results database. Competing risks analysis was used to assess the cumulative incidence of breast cancer-specific mortality (BCSM). Multivariable Fine-Gray regression was used to identify predictors of BCSM. Women age 70+ (n = 4221) were less likely to receive chemotherapy and radiation treatment (P < 0.0001) and had higher BCSM compared to younger women (P < 0.0001). There were no differences in BCSM in patients who received adjuvant treatment (P = 0.10). Stage II patients derived the greatest relative and absolute benefit from adjuvant treatment. Age was not a significant predictor of BCSM.

引用

页码：469 / 473

页数：5

共 16 条

[1] Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Biganzoli, Laura
Wildiers, Hans
Oakman, Catherine
Marotti, Lorenza
Loibl, Sibylle
Kunkler, Ian
Reed, Malcolm
Ciatto, Stefano
Voogd, Adri C.
Brain, Etienne
Cutuli, Bruno
Terret, Catherine
Gosney, Margot
Aapro, Matti
Audisio, Riccardo
[J]. LANCET ONCOLOGY, 2012, 13 (04) : E148 - E160
[2] Older female cancer patients: Importance, causes, and consequences of undertreatment
Bouchardy, Christine
Rapiti, Elisabetta
Blagojevic, Stina
Vlastos, Anne-Therese
Vlastos, Georges
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (14) : 1858 - 1869
[3] Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort
Elkin, Elena B.
Hurria, Arti
Mitra, Nandita
Schrag, Deborah
Panageas, Katherine S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2757 - 2764
[4] A comprehensive geriatric intervention detects multiple problems in older breast cancer patients
Extermann, M
Meyer, J
McGinnis, M
Crocker, TT
Corcoran, MB
Yoder, J
Haley, WE
Chen, HB
Boulware, D
Balducci, L
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 49 (01) : 69 - 75
[5] Treatment of Breast Cancer in the Elderly
Freedman, Rachel A.
[J]. CURRENT ONCOLOGY REPORTS, 2015, 17 (11)
[6] Use and outcomes of adjuvant chemotherapy in older women with breast cancer
Giordano, Sharon H.
Duan, Zhigang
Kuo, Yong-Fang
Hortobagyi, Gabriel N.
Goodwin, James S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2750 - 2756
[7] Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
Inwald, E. C.
Ortmann, O.
Koller, M.
Zeman, F.
Hofstaedter, F.
Evert, M.
Brockhoff, G.
Klinkhammer-Schalke, M.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 119 - 130
[8] Triple-negative breast cancer in the elderly: Prognosis and treatment
Kaplan, Henry G.
Malmgren, Judith A.
Atwood, Mary K.
[J]. BREAST JOURNAL, 2017, 23 (06) : 630 - 637
[9] Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Kassam, Farrah
Enright, Katherine
Dent, Rebecca
Dranitsaris, George
Myers, Jeff
Flynn, Candi
Fralick, Michael
Kumar, Ritu
Clemons, Mark
[J]. CLINICAL BREAST CANCER, 2009, 9 (01) : 29 - 33
[10] The prognostic impact of age in patients with triple-negative breast cancer
Liedtke, Cornelia
Hess, K. R.
Karn, T.
Rody, A.
Kiesel, L.
Hortobagyi, G. N.
Pusztai, L.
Gonzalez-Angulo, A. M.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (02) : 591 - 599

← 1 2 →